PulseAugur
实时 21:49:37
实体 Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself

Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself

PulseAugur coverage of Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself — every cluster mentioning Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself across labs, papers, and developer communities, ranked by signal.

Show in brief
总计 · 30天
1
90 天内 1
发布 · 30天
0
90 天内 0
论文 · 30天
0
90 天内 0
层级分布 · 90 天
主题
情绪 · 30 天

1 天有情绪数据

最近 · 第 1/1 页 · 共 1 条
  1. COMMENTARY · CL_101935 ·

    讨论人工智能在淋巴瘤免疫疗法中的作用

    Yan Leyfman 讨论了人工智能在淋巴瘤免疫疗法中的作用,特别关注 TLR9 对这种治疗的必要性。讨论强调了 TLR9 在宿主或肿瘤本身中对于有效免疫疗法的必要性。